Cargando…
Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles
GPR17 is a G-protein-coupled receptor (GPCR) implicated in the regulation of glucose metabolism and energy homeostasis. Such evidence is primarily drawn from mouse knockout studies and suggests GPR17 as a potential novel therapeutic target for the treatment of metabolic diseases. However, links betw...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267566/ https://www.ncbi.nlm.nih.gov/pubmed/34144038 http://dx.doi.org/10.1016/j.jbc.2021.100881 |